RJA
GSK icon

Ross\Johnson & Associates’s GSK GSK Stock Holding History

Ross\Johnson & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32K Hold
24
– – 0.02% 78
2025
Q4 		$1.18K Hold
24
– – 0.02% 87
2025
Q3 		$1.04K Hold
24
– – 0.02% 80
2025
Q2 		$922 Hold
24
– – 0.02% 80
2025
Q1 		$930 Hold
24
– – 0.02% 213
2024
Q4 		$812 Buy
+24
New +$864 0.02% 84

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ross\Johnson & Associates's GSK Position: Q1 2026 in Review

Ross\Johnson & Associates held its GSK (GSK) position steady in Q1 2026 at 24 shares worth $1.32K. The position accounts for 0.02% of the portfolio, ranked #78.

Ross\Johnson & Associates first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Ross\Johnson & Associates held 24 shares of GSK worth $1.32K as of Q1 2026.
  • Ross\Johnson & Associates left its GSK share count unchanged in Q1 2026.
  • GSK made up 0.02% of Ross\Johnson & Associates's portfolio in Q1 2026, its #78 holding.
  • Ross\Johnson & Associates first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.